Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Prime Medicine (PRME) Shares Issued (2022 - 2025)

Prime Medicine filings provide 4 years of Shares Issued readings, the most recent being $408000.0 for Q4 2025.

  • On a quarterly basis, Shares Issued fell 97.88% to $408000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $781000.0, a 97.95% decrease, with the full-year FY2025 number at $781000.0, down 97.95% from a year prior.
  • Shares Issued hit $408000.0 in Q4 2025 for Prime Medicine, up from $373000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $19.3 million in Q4 2024 to a low of -$1.1 million in Q2 2024.
  • Median Shares Issued over the past 4 years was $264500.0 (2022), compared with a mean of $3.3 million.
  • The widest YoY moves for Shares Issued: up 13197.2% in 2024, down 1605.33% in 2024.
  • Prime Medicine's Shares Issued stood at $156000.0 in 2022, then soared by 319.87% to $655000.0 in 2023, then skyrocketed by 2843.66% to $19.3 million in 2024, then crashed by 97.88% to $408000.0 in 2025.
  • The last three reported values for Shares Issued were $408000.0 (Q4 2025), $373000.0 (Q3 2025), and $19.3 million (Q4 2024) per Business Quant data.